The COVID Advisor

More than four years following the emergence of COVID-19, a subset of individuals experience persistent, multisystem symptoms extending beyond three months post-infection or post-exposure to mRNA-based COVID-19 vaccines.  This condition, historically termed "Long COVID," has recently been redefined by some researchers as "Post-Spike Syndrome" (PSS) or "SPIKEOPATHY," emphasizing the pathogenic role of the SARS-CoV-2 Spike protein derived from both viral infection and mRNA vaccination.  This article summarizes the most recent scientific findings and clinical advances to help patients and healthcare providers better understand and manage this complex condition. Latest Research Insights on Long COVID Immune System Markers and Genetic Risk Factors A recent clinical study led by Cardiff Metropolitan University and Cwm Taf Morgannwg University Health Board identified elevated levels of the immune protein Interleukin-6 (IL-6) in people suffering from Long COVID co...

Federal  data  published by the US CDC found that 17.9% (National Estimate) of adults who previously had a COVID-19 infection are currently experiencing symptoms of long COVID. Females tend to have a relatively higher risk as compared to males. If you’re still coping with symptoms three months or more after being infected with COVID-19, you’re considered a COVID long-hauler.  As we learn more about post-COVID syndrome, however, the  definition has been refined  to be more accurate and useful: Subacute or ongoing COVID-19 (post-acute COVID-19 syndrome): symptoms continuing beyond four weeks from acute infection, up to 12 weeks. Post-acute sequelae of COVID-19 (PASC): symptoms persisting beyond the four weeks after acute infection. Post-COVID-19 syndrome (long COVID, long-hauler’s syndrome): chronic ongoing COVID-19 symptoms beyond 12 weeks from acute infection. With 200-plus symptoms linked to long COVID, treatment starts by pinpointing specific medical condition...